Corpus Christi Medical Center, Corpus Christi, TX
Copyright 2016, American College of Chest Physicians. All Rights Reserved.
SESSION TITLE: Airways 1
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: The most recent GOLD Guidelines recognize a patient’s symptoms as an integral part of assessing the risk category of the disease. Subjective validated tests like the COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) were utilized to risk stratify the patients. We undertook this study to assess the utilization of the CAT and mMRC questionnaires in risk stratifying the COPD patient in a community family practice clinic.
METHODS: After approval from the local IRB, a retrospective chart review was done among all patients with the diagnosis of COPD. Baseline demographics and utilization of CAT and mMRC questionnaires in any progress notes were assessed. Pack-years of tobacco use, exacerbation history and use of home oxygen were also obtained.
RESULTS: Chart reviews of 65 patients were completed (32 Male; 33 female). An average age of 70.27 (+/-10.88) years, average BMI of 29.52 (+/- 8.79) and an average of 33.96 (+/-30.92) pack-years were found. 32.3% (21/65) of patients had exacerbation during the past one year and 4.6% (3/65) of subjects had required endotracheal intubation. 20% of the patients studied are currently on home oxygen (13/65). None of the patients with the diagnosis of COPD underwent the assessment of symptoms via utilization of CAT or mMRC questionnaire on any progress note.
CONCLUSIONS: The subjective symptoms assessed using either the CAT or mMRC questionnaires were not utilized in any patients with the diagnosis of COPD. Evaluation of subjective symptoms via CAT or mMRC in addition to exacerbation history have been key aspects of the updated GOLD Guidelines since 2011, but there seems to be some disconnect in utilizing this guideline in the primary care office setting.
CLINICAL IMPLICATIONS: Educational efforts and collaboration between different medical societies need to be undertaken to improve the diagnosis and management of patients with COPD.
DISCLOSURE: The following authors have nothing to disclose: Stephen Eikermann, Timothy Murphy, Antonio Guzman, David Vanderheiden, Salim Surani
No Product/Research Disclosure Information
Become a CHEST member and receive a FREE subscription as a benefit of membership.
Individuals can purchase this article on ScienceDirect.
Individuals can purchase a subscription to the journal.
Individuals can purchase a subscription to the journal or buy individual articles.
Learn more about membership or Purchase a Full Subscription.
Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited:
Customize your page view by dragging & repositioning the boxes below.
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.